Uniunea Europeană - română - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostate neoplasme - terapia endocrină - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

astellas pharma europe b.v. - enzalutamidum - capsule moi - 40 mg

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - enzalutamidum - compr. film. - 40mg - antagonisti hormonali si substante inrudite antiandrogeni

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

lek pharmaceuticals d.d. - slovenia - enzalutamidum - compr. film. - 80mg - antagonisti hormonali si substante inrudite antiandrogeni

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

astellas pharma europe b.v. - olanda - enzalutamidum - compr. film. - 40mg - antagonisti hormonali si substante inrudite antiandrogeni